Inventor · disambiguated record
Kehao Zhao
Also filed as: ZHAO KEHAO
8 granted patents·15 pending applications·28 citations·filing 2008–2024
82Inventor score
Files withNOVARTIS AG11ELPIS BIOPHARMACEUTICALS9CHAN HO MAN1SHANDONG BOAN BIOTECHNOLOGY CO LTD1UNIV PITTSBURGH COMMONWEALTH SYS HIGHER EDUCATION1
Top patents by PatentIndex Score
23 records- 0193US11207325B2Triazolopyrimidine compounds and uses thereofNOVARTIS AG·Filed 2020·Granted Dec 28, 2021·3 cites·19 claims
- 0289US9580437B2Triazolopyrimidine compounds and uses thereofCHAN HO MAN·Filed 2015·Granted Feb 28, 2017·15 cites·20 claims
- 0381US10689378B2Triazolopyridine compounds and uses thereofNOVARTIS AG·Filed 2017·Granted Jun 23, 2020·4 cites·18 claims
- 0481US10220036B2Triazolopyrimidine compounds and uses thereofNOVARTIS AG·Filed 2015·Granted Mar 5, 2019·3 cites·26 claims
- 0579US10676479B2Imidazolepyridine compounds and uses thereofNOVARTIS AG·Filed 2017·Granted Jun 9, 2020·2 cites·10 claims
- 0675US11931363B2Triazolopyrimidine compounds and uses thereofNOVARTIS AG·Filed 2021·Granted Mar 19, 2024·0 cites·22 claims
- 0774US12492252B2Anti-GPC3 antibody, anti-GPC3 chimeric antigen receptor and GPC3/CD3 bispecific antibodySHANDONG BOAN BIOTECHNOLOGY CO LTD·Filed 2021·Granted Dec 9, 2025·1 cites·20 claims
- 0866US2025326813A1Engineered interleukin-2 receptor beta reduced-binding agonistELPIS BIOPHARMACEUTICALS·Filed 2023·Application pending·0 cites
- 0965US2024216378A1Triazolopyrimidine compounds and uses thereofNOVARTIS AG·Filed 2024·Application pending·0 cites
- 1062US2019142837A1Triazolopyrimidine compounds and uses thereofNOVARTIS AG·Filed 2019·Application pending·0 cites
- 1157US2024368275A1Anti-nectin4 antibodies and multi-specific protein complexes comprising suchELPIS BIOPHARMACEUTICALS·Filed 2022·Application pending·0 cites
- 1257US2025340646A1Anti-pd-l1 monoclonal antibodies and fusion proteins with interleukin-15, interleukin-15 receptor alpha, or interleukin-2ELPIS BIOPHARMACEUTICALS·Filed 2022·Application pending·0 cites
- 1356US2024336683A1Antibodies specific to sialic acid-binding ig-like lectin 15 and uses thereofELPIS BIOPHARMACEUTICALS·Filed 2022·Application pending·0 cites
- 1454US2023220053A1ANTI-SARS-CoV-2 ANTIBODIES AND USES THEREOFELPIS BIOPHARMACEUTICALS·Filed 2021·Application pending·0 cites
- 1551US12473273B2Quinoline compounds and compositions for inhibiting EZH2NOVARTIS AG·Filed 2021·Granted Nov 18, 2025·0 cites·19 claims
- 1651US2024082402A1Bispecific chimeric antigen receptors binding to cd19 and cd22ELPIS BIOPHARMACEUTICALS·Filed 2022·Application pending·0 cites
- 1750US2024230983A1System and method for fabricating multiplexable active optical fiber sensorsUNIV PITTSBURGH COMMONWEALTH SYS HIGHER EDUCATION·Filed 2022·Application pending·0 cites
- 1849US2022298257A1Anti-cd22 antibodies and uses thereofELPIS BIOPHARMACEUTICALS·Filed 2020·Application pending·0 cites
- 1949US2022289843A1Anti-cd19 antibodies and uses thereofELPIS BIOPHARMACEUTICALS·Filed 2020·Application pending·0 cites
- 2048US2009175875A1Molecules and Methods for Modulating Complement ComponentNOVARTIS AG·Filed 2008·Application pending·0 cites
- 2147US2010166748A1C5 Antigens and Uses ThereofNOVARTIS AG·Filed 2008·Application pending·0 cites
- 2246US2023002466A1Engineered interleukin-2 receptor beta agonistsELPIS BIOPHARMACEUTICALS·Filed 2020·Application pending·0 cites
- 2334US2010291106A1Compositions and methods for antibodies targeting complement protein c3bNOVARTIS AG·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kehao Zhao files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →